This Month in Psychopharmacology

Highlights from 2024 NEI Synapse: Don’t Get Mixed Up! Recognizing and Treating Mixed Features Across the Lifespan

One of the most overlooked and underdiagnosed manifestations along ...

Read More

FDA Approves Treatment for Mixed, Manic Episodes Associated With Bipolar I Disorder

The FDA has expanded the approval iloperidone to include for the ac...

Read More

World Bipolar Day Is Celebrated Each Year On March 30th

World Bipolar Day is celebrated each year on March 30th. World Bipo...

Read More

Efficacy of Cariprazine in Patients with Bipolar Depression and Comorbid Anxiety

A recent post-hoc analysis suggest that cariprazine is a viable tre...

Read More

Bipolar Disorder and Cumulative Trauma

A recent review underscores the high prevalence and adverse impacts...

Read More

Liraglutide for Weight Loss in Stable Bipolar Disorder

An all-too-common comorbidity for those suffering with bipolar diso...

Read More

Clinical Features in Co-Occuring OCD and Bipolar Disorder

Obsessive-compulsive disorder and bipolar disorder are found comorb...

Read More

Vitamin B6 As An Adjunctive Therapy To Lithium

Recent strides in psychiatric research have delved into adjunctive ...

Read More

Blood Test to Diagnose Bipolar Disorder

A recent study aimed to differentiate bipolar disorder from major ...

Read More

Screening for Eating Disorders in Patients with Bipolar Disorder

Bipolar disorder is a prevalent and debilitating psychiatric condit...

Read More

Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression

Antidepressants are commonly prescribed to treat acute depressive ...

Read More

FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder

The U.S. Food and Drug Administration has approved a new drug appli...

Read More